-->

Tag: Toripalimab FDA approval

Home / Toripalimab FDA approval

Categories

Toripalimab-tpzi is approved by the FDA for nasopharyngeal carcinoma

In October 2023, the FDA approved toripalimab-tpzi (LOQTORZ, Coherus BioSciences, Inc.) with cisplatin and gemcitabine as the first-line treatment for people with locally advanced nasopharyngeal canc...
toripalimab-fda-approval

Scan the code